Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
six
months ended in Feb. 2026,
Dis-Chem Pharmacies paidR60 Mil more to buy back shares than it received from issuing new shares.
It receivedR7 Mil from issuing more debt.
It paidR0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It receivedR0 Mil from paying cash dividends to shareholders.
It spentR22 Mil on other financial activities.
In all, Dis-Chem PharmaciesspentR75 Mil on financial activities for the
six
months ended in Feb. 2026.
Dis-Chem Pharmacies (JSE:DCP) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Dis-Chem Pharmacies's issuance of stock for the
six
months ended in Feb. 2026 was R0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Dis-Chem Pharmacies's repurchase of stock for the
six
months ended in Feb. 2026 was R-60 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Dis-Chem Pharmacies's net issuance of debt for the
six
months ended in Feb. 2026 was R7 Mil.
Dis-Chem Pharmacies receivedR7 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Dis-Chem Pharmacies's net issuance of preferred for the
six
months ended in Feb. 2026 was R0 Mil.
Dis-Chem Pharmacies paidR0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Dis-Chem Pharmacies's cash flow for dividends for the
six
months ended in Feb. 2026 was R0 Mil.
Dis-Chem Pharmacies receivedR0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Dis-Chem Pharmacies's other financing for the
six
months ended in Feb. 2026 was R-22 Mil.
Dis-Chem Pharmacies spentR22 Mil on other financial activities.
Dis-Chem Pharmacies Cash Flow from Financing Related Terms
Dis-Chem Pharmacies Cash Flow from Financing Historical Data
* Premium members only.
The historical data trend for Dis-Chem Pharmacies's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dis-Chem Pharmacies Cash Flow from Financing Chart
Dis-Chem Pharmacies Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Dis-Chem Pharmacies's Cash from Financing for the fiscal year that ended in Feb. 2026 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was R-995 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of R-995 Mil mean?
Dis-Chem Pharmacies (JSE:DCP) has a Cash Flow from Financing of R-995 Mil as of Feb. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Dis-Chem Pharmacies and its competitors.
Is Dis-Chem Pharmacies' Cash Flow from Financing too high?
Dis-Chem Pharmacies' current Cash Flow from Financing is R-995 Mil. Overall, Dis-Chem Pharmacies has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' Cash Flow from Financing compare to competitors?
Dis-Chem Pharmacies' Cash Flow from Financing of R-995 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Healthcare Providers & Services company?
A good Cash Flow from Financing depends on the Healthcare Providers & Services industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Dis-Chem Pharmacies and its competitors. Dis-Chem Pharmacies's current Cash Flow from Financing is R-995 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.35, compared to a current price of R29.99 — trading 21.8% below its estimated fair value. The current Cash Flow from Financing is R-995 Mil. Dis-Chem Pharmacies' overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current Cash Flow from Financing is R-995 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?
Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued.
The current stock price of R29.99 is trading 21.8% below its estimated GF Value™ of R38.35.
GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.
Key valuation signals for JSE:DCP:
Cash Flow from Financing: R-995 Mil
GF Value™: R38.35 vs. price of R29.99 (21.8% below fair value)
No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
84GF Score
Get the complete analysis for JSE:DCP
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:DCP has been successfully added to your 
